$11.27
00.00%
Pre-Market: Sep 20, 4:03 PM EDT
15 minutes delayed
Cidara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cidara Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-2.05 | $-4.10 | 50.0 % |
Mar 2024 | 2024-05-15 | $-2.28 | $-0.80 | -185.0 % |
Mar 2024 | 2024-04-22 | $-0.80 | $-2.00 | 60.0 % |
Sep 2023 | 2023-11-02 | $-1.80 | $-3.20 | 43.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $302.00K | $4.70M | -93.6 % |
Mar 2024 | 2024-05-15 | $8.46M | $9.03M | -6.28 % |
Mar 2024 | 2024-04-22 | $17.58M | $11.54M | 52.4 % |
Sep 2023 | 2023-11-02 | $12.72M | $8.14M | 56.2 % |
Cidara Therapeutics (CDTX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-2.05, which beat the estimate of $-4.10.
The Actual Revenue was $302K, which missed the estimate of $4.7M.
Browse earnings estimates, EPS, and revenue on all stocks.